Indivior Pharmaceuticals Inc (INDV)

Apr 03, 2026

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN

Apr 03, 2026

Apr 03, 2026

JPMorgan Chase & Co. Has $5.01 Million Holdings in Indivior PLC $INDV - marketbeat.com

Apr 03, 2026

Apr 03, 2026

Did Potential Jail Staffing Efficiencies From SUBLOCADE® Just Shift Indivior Pharmaceuticals' (INDV) Investment Narrative? - Sahm

Apr 03, 2026

Apr 02, 2026

Indivior Pharmaceuticals Inc. R (E7P.F) Valuation Measures & Financial Statistics - Yahoo! Finance Canada

Apr 02, 2026

Apr 02, 2026

Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Indivior Pharmaceuticals Inc. (INDV) - MSN

Apr 02, 2026

Apr 01, 2026

What Indivior Pharmaceuticals (INDV)'s Prison Cost Model Findings Mean For Shareholders - Yahoo Finance

Apr 01, 2026

Apr 01, 2026

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - The Globe and Mail

Apr 01, 2026

Mar 31, 2026

Indivior Pharmaceuticals, Inc - Reuters

Mar 31, 2026

Mar 31, 2026

Ultragenyx Pharmaceutical Announces FDA Acceptance of UX016 IND - TradingView

Mar 31, 2026

Mar 31, 2026

New Cost Impact Model Highlights Potential Benefits of Monthly Injectable Buprenorphine - National Today

Mar 31, 2026

Mar 31, 2026

New Cost Model Shows Monthly Injectable Buprenorphine Can Reduce Staffing Burdens in Prisons - National Today

Mar 31, 2026

Mar 31, 2026

New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities - manilatimes.net

Mar 31, 2026

Mar 31, 2026

Monthly opioid addiction shot may cut jail staffing, model estimates - Stock Titan

Mar 31, 2026

Mar 31, 2026

Zacks.com spotlights Indivior, Ciena, and Ultra Clean as notable mentions - Bitget

Mar 31, 2026

Mar 31, 2026

Zacks.com featured highlights include Indivior, Ciena and Ultra Clean - Yahoo Finance

Mar 31, 2026

Mar 31, 2026

FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policies - Sahm

Mar 31, 2026

Mar 31, 2026

Indivior PLC (NASDAQ:INDV) Short Interest Up 21.7% in March - MarketBeat

Mar 31, 2026

Mar 30, 2026

Indivior: Still Attractive After FY25 Earnings Beat (NASDAQ:INDV) - Seeking Alpha

Mar 30, 2026

Mar 30, 2026

Is It Time To Reassess Indivior Pharmaceuticals (INDV) After Its 200% One Year Surge? - simplywall.st

Mar 30, 2026

Mar 30, 2026

Hennion & Walsh Asset Management Inc. Purchases 96,177 Shares of Indivior PLC $INDV - MarketBeat

Mar 30, 2026

Mar 29, 2026

If You Invested $1,000 in Indivior Pharmaceuticals Inc. (INDV) - Stock Titan

Mar 29, 2026

Mar 29, 2026

SG Americas Securities LLC Buys 363,829 Shares of Indivior PLC $INDV - MarketBeat

Mar 29, 2026

Mar 29, 2026

Indivior PLC (NASDAQ:INDV) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Mar 29, 2026

Mar 28, 2026

Levi & Korsinsky Reminds Indivior Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 1, 2024INDV - MarketScreener

Mar 28, 2026

Mar 27, 2026

Indivior (INDV) posts 2025 growth, SUBLOCADE gains and $400M buyback in 2026 proxy - Stock Titan

Mar 27, 2026

Mar 27, 2026

Suboxone Market Size Forecasts 2026-2033: Analyzing Industry - openPR.com

Mar 27, 2026

Mar 25, 2026

Indivior PLC Stock Faces Uncertainty Amid U.S. Domicile Shift and OUD Market Focus - AD HOC NEWS

Mar 25, 2026

Mar 25, 2026

Indivior Pharmaceuticals Inc (INDV) Shares Up 5.07% on Mar 25 - GuruFocus

Mar 25, 2026

Mar 25, 2026

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B (XLV:NYSEARCA) - Seeking Alpha

Mar 25, 2026

Mar 25, 2026

Down 12.9% Over the Past Month: Reasons to Consider Purchasing Indivior Pharmaceuticals Inc. (INDV) During the Decline - Bitget

Mar 25, 2026

Mar 24, 2026

FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug - TradingView

Mar 24, 2026

Mar 23, 2026

[SCHEDULE 13G] Indivior Pharmaceuticals, Inc. Passive Investment Disclosure (>5%) - Stock Titan

Mar 23, 2026

Mar 23, 2026

Indivior Pharmaceuticals to report Q4 earnings: What's in the cards? - MSN

Mar 23, 2026

Mar 21, 2026

A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Recent Share Price Weakness - Sahm

Mar 21, 2026

Mar 20, 2026

Implied volatility surging for Indivior Pharmaceuticals stock options - MSN

Mar 20, 2026

Mar 20, 2026

Indivior Pharmaceuticals Inc (INDV) Shares Gap Down to $29.44 on Mar 20 - GuruFocus

Mar 20, 2026

Mar 19, 2026

Indivior (NASDAQ:INDV) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat

Mar 19, 2026

Mar 19, 2026

Goldentree Asset Management LP Makes New Investment in Indivior PLC $INDV - MarketBeat

Mar 19, 2026

Mar 18, 2026

Indivior outlines 30% adjusted EBITDA growth target for 2026 with new $400M share repurchase program - MSN

Mar 18, 2026

Mar 17, 2026

Indivior Issues $500 Million Convertible Senior Notes Offering - TipRanks

Mar 17, 2026

Mar 17, 2026

[Form 4] Indivior Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan

Mar 17, 2026

Mar 17, 2026

Indivior Pharmaceuticals Raises $500 Million Via 0.625% Convertible Notes Due 2031 - TradingView

Mar 17, 2026

Mar 17, 2026

Indivior Pharmaceuticals Survey Reveals Gaps in Medications for Opioid Use Disorder in U.S. Jails and Prisons - Quiver Quantitative

Mar 17, 2026

Mar 17, 2026

National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder - GlobeNewswire

Mar 17, 2026

Mar 16, 2026

Indivior plans $400M convertible senior notes offering - MSN

Mar 16, 2026

Mar 16, 2026

Indivior PLC $INDV Shares Acquired by Divisadero Street Capital Management LP - MarketBeat

Mar 16, 2026